Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421237 · ClinicalTrials.gov registry record · NA
Trial of Treatment for Internalized Stigma in Schizophrenia
A NA study, sponsored by John Jay College of Criminal Justice, City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 170
- Enrollment target
NCT02421237: Completed NA study, sponsored by John Jay College of Criminal Justice, City University of New York.
NCT02421237 is a NA study that has completed, run by John Jay College of Criminal Justice, City University of New York. The registered enrollment target is 170 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02421237, a NA study, has completed, sponsored by John Jay College of Criminal Justice, City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
Study Summary
The purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled trial of the Narrative Enhancement/Cognitive Therapy (NECT) intervention among persons with schizophrenia-spectrum disorders.
Interventions
- BEHAVIORAL Supportive Group Therapy
- BEHAVIORAL Narrative Enhancement and Cognitive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
What the finished NCT02421237 record still lists
NCT02421237 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Supportive Group Therapy is the first listed.
NCT02421237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02421237 about?
NCT02421237 is a clinical study titled "Trial of Treatment for Internalized Stigma in Schizophrenia". The purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled trial of the Narrative Enhancement/Cognitive Therapy (NECT) intervention among persons with schizophrenia-spectrum disor...
What is the current status of trial NCT02421237?
This trial is currently completed. It is a NA study. The enrollment target is 170 participants. The study started on 2013-03. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT02421237?
The interventions under investigation include: Supportive Group Therapy (BEHAVIORAL), Narrative Enhancement and Cognitive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02421237?
This trial is sponsored by John Jay College of Criminal Justice, City University of New York, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02421237's enrollment target sits among peer trials
170 614th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia